Beverly Glen Laboratories

Health & Beauty · Skincare

Beverly Glen Laboratories sells dermatologist-formulated skin-care treatments centered on a patented “QuSome®” encapsulation technology. The range spans cleansers, serums, moisturizers, and targeted treatments priced in the premium tier, with most single items between $80 and $180. Distribution is DTC through bglen.us and a company-run clinic in Beverly Hills; no third-party e-tailers or department-store counters are used. The brand’s identity rests on QuSome®, a liposomal delivery system that stabilizes and drives actives such as retinol, vitamin C, and niacinamide deeper into the stratum corneum. Clinically styled packaging, small-batch manufacturing in Japan, and published in-house efficacy data reinforce a lab-over-luxury positioning. The C-Quence serum and QuSome Moisture Rich Cream are the flagships repeatedly cited in customer media. Core buyers are 35-55-year-old professionals, evenly split between women and men, who want measurable correction for sun damage, fine lines, and uneven tone without injectables or procedural downtime. They value science-backed narratives, ingredient transparency, and concierge-level online support that includes video consults with the formulation team. Beverly Glen Laboratories competes with physician-dispensed and high-performance cosmeceutical lines that also promise clinical-grade results. It differentiates by owning the QuSome® patent, limiting SKU count to eight hero products, and controlling the entire supply chain from R&D to doorstep, ensuring freshness and reducing counterfeits.

Science-backed skin correction, delivered fresh from the lab to your door